BACKGROUND It is well known that low-density lipoprotein cholesterol (LDL-C) is a risk factor for atherosclerosis. However, the relationship between admission LDL levels and clinical outcome in patients underwent percutaneous coronary intervention (PCI) has not been established. The aim of this study was to evaluate the effect of admission LDL-C on short-and long-term clinical outcomes.
BACKGROUND It is well known that low-density lipoprotein cholesterol (LDL-C) is a risk factor for atherosclerosis. However, the relationship between admission LDL levels and clinical outcome in patients underwent percutaneous coronary intervention (PCI) has not been established. The aim of this study was to evaluate the effect of admission LDL-C on short-and long-term clinical outcomes.
METHODS Among patients underwent PCI from single center prospective registry, total 2,638 patients without history of dyslipidemia and with fasting lipid profiles measured within 24 hours of admission were selected for analysis. Patients were divided into 4 groups according to the quartile of LDL-C as: Q1 (<86 mg/dl; n ¼ 655), Q2 (86 to 109 mg/dl; n ¼ 657), Q3 (110 to 134 mg/dl; n ¼ 655), and Q4 (LDL-C >134; n ¼ 671). Primary endpoint was patient-oriented composite outcome (POCO) consisted with any death, myocardial infarction, and any revascularization for 3-year of follow-up. Secondary endpoint was any death at 30 days after index PCI.
RESULTS When compared with other groups, patients in Q1 group were older and thinner. The incidence of hypertension, diabetes, chronic kidney disease, previous myocardial infarction, previous PCI was higher in Q1 group. The incidence of myocardial infarction was similar among groups. Although, the rate of multi-vessel disease and multi-vessel PCI was similar among groups, PCI for chronic total occlusion was most frequent in Q1 group. (HTN) is known to be a risk factor of significant coronary artery disease (CAD). However, currently there is no enough available data with larger study population with long-term clinical outcomes of significant coronary artery spasm (CAS) patients (pts) with HTN in real world clinical practice.
METHODS A total of 3,349 consecutive pts without significant CAD underwent acetylcholine (Ach) provocation test and only pts with significant CAS were enrolled. Significant CAS was defined as > 70% of narrowing by incremental intracoronary injection of 20, 50 and 100 mg into left coronary artery. Pts were divided into two groups based on the presence of HTN: the HTN group (n¼1,489), the Normotensive group (n¼1,860). To adjust potential confounders, a propensity score matched (PSM) analysis was performed using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (1,143pairs, n ¼ 2,286, C-statistic¼0.720) were generated and, the baseline characteristics of the two groups were balanced. In clinical outcomes up to5-year, there were similar incidence of individual hard endpoints including mortality, myocardial infarction, revascularization and recurrent angina requiring repeat coronary angiography. Hypertension was not an independent predictor of adverse clinical outcomes in pts with CAS (Table) .
CONCLUSION Despite the expected endothelial dysfunction, hypertension was not associated with a worsening factor for adverse clinical outcomes in pts with significant CAS documented by intracoronary Achprovocation test, suggesting that the mechanisms and risk factors of CAS may be different from those of atherosclerotic CAD. 
